COMMUNIQUÉS West-GlobeNewswire

Amedisys Closes on Acquisition Expanding Personal Care to Tennessee

02/05/2018 - 13:00

BATON ROUGE, La., May 02, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED ), one of the nation’s leading home healthcare, hospice and personal care companies, announced today that its subsidiary, Associated Home [...]

Akcea Announces Expansion of Global Early Access Program to Provide Volanesorsen to People Living with FCS

02/05/2018 - 13:00

Program currently available in the U.S. and select countries in Europe; initiating additional countries throughout 2018 CAMBRIDGE, Mass., May 02, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA ) today [...]

miRagen Therapeutics to Report First Quarter 2018 Financial Results and Host Conference Call on May 9, 2018

02/05/2018 - 13:00

BOULDER, Colo., May 02, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN ), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, will host a [...]

Solon Eiendom ASA : Primary insider notification

02/05/2018 - 11:19

(Oslo, Norway, May 02, 2018) Solon Eiendom ASA Chairman of the Board Simen Thorsen has today transferred 4,000,000 shares in Solon Eiendom ASA from his wholly owned company Hortulan AS at a price of NOK 25.00 per share [...]

Medtronic Announces FDA Approval of Infuse(TM) Bone Graft in New Spine Surgery Indications Using PEEK Interbody Implants

02/05/2018 - 11:11

Approval Adds Two Additional Implants to Current Spine Labeling DUBLIN - April 30, 2018 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of Infuse(TM) Bone Graft in new spine [...]

Amarin Reports First Quarter 2018 Financial Results and Provides Update on Operations

02/05/2018 - 11:00

REDUCE-IT Study On-Track for Reporting Top-Line Results by the End of Q3 2018 Management to Host Conference Call at 7:30 a.m. ET Today BEDMINSTER, N.J. and DUBLIN, Ireland, May 02, 2018 (GLOBE NEWSWIRE) -- Amarin [...]

AC Immune Reports First Quarter 2018 Financial Results and Corporate Update

02/05/2018 - 10:00

Announced first-in-human study for an alpha-synuclein PET tracer for Parkinson's disease Selected Tau small molecules (Tau Morphomers) have entered into IND/CTA * enabling studies; Phase 1 to commence by the end of 2018 [...]

Minerv Supertoys bioplastic for toys to be showcased at "BioPlastics: Biobased Re-Invention of Plastics" in New York

02/05/2018 - 09:41

Bio-on and ITALERI confirm their alliance for the toys of the future. Product now goes to the market and the toys supply chain following completion of the test phase. Bio-on repeats its commitment to environmental [...]

Trading by management and close relations of management

02/05/2018 - 09:40

Read the full announcement in the attached file Attachment 2018_22_Trading_by_management_EN

Investor meeting on May 3, 2018.

02/05/2018 - 09:39

In connection with the release of BioPorto’s interim report covering the first quarter of 2018, BioPorto will hold an investor meeting on May 3, 2018 at 3 pm. at Tuborg Havnevej 15, st, 2900 Hellerup, Denmark. [...]

Notification from Oasmia Pharmaceutical AB

02/05/2018 - 08:45

Oasmia Pharmaceutical AB hereby issues a notification that the Company has submitted a Form F-3 to SEC which is a required document in case the Company would need to do a financial transaction in the US during the [...]

Novo Nordisk's operating profit decreased by 8% in Danish kroner and increased by 6% in local currencies in the first three months of 2018

02/05/2018 - 07:32

Sales decreased by 5% in Danish kroner and increased by 5% in local currencies to DKK 26.9 billion. Sales of Victoza® increased by 4% to DKK 6.0 billion (18% in local currencies). Sales of Tresiba® increased by 18% to [...]

Targovax announces early signal of efficacy in ONCOS-102 trial in mesothelioma

02/05/2018 - 07:01

Responses observed in three out of six patients Recruitment into the randomized part of the trial underway Oslo, Norway, 2 May 2018 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno- [...]

Interim Report Q1 2018: Double digit organic growth drives strong EBITA margin increase. GN Audio upgrades organic growth guidance

02/05/2018 - 07:00

GN Store Nord delivered 10% organic revenue growth in Q1 2018. Revenue growth was 3% including around (7)% impact from development in foreign exchange rates EBITA margin increased 1.1 percentage points in Q1 2018 [...]

Initiation of new share buyback program

02/05/2018 - 06:53

Based on the continued solid business performance and GN’s capital structure policy and in accordance with the authorization granted to the Board of Directors at the annual general meeting on 13 March 2018, GN announces [...]

BeiGene Appoints Senior Pharmaceutical Executive Dr. Xiaobin Wu as General Manager of China and President of BeiGene, Ltd.

02/05/2018 - 01:00

BEIJING, China and CAMBRIDGE, Mass., May 01, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted [...]

REVA to Hold First Quarter 2018 Financial Results Call

02/05/2018 - 00:57

SAN DIEGO, May 01, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) has scheduled a conference call to review its first quarter 2018 financial results and provide a business update. The [...]

Onconova Therapeutics Announces Closing of $28.75 Million Upsized Underwritten Public Offering

02/05/2018 - 00:33

Underwriter’s Option to Purchase Additional Securities Exercised in Full NEWTOWN, Pa., May 01, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX ) (“Onconova” or “we”), a Phase 3 stage biopharmaceutical [...]

IntelGenx Announces Proposed Private Placement

01/05/2018 - 23:25

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES SAINT LAURENT, Quebec, May 01, 2018 (GLOBE NEWSWIRE) -- IntelGenx [...]